In today’s fast-paced world, where the stresses of daily life often take a toll on our health, it is essential to find ...

Investors can benefit from TDS' preferred shares trading below par with attractive yields and potential for price ...

The J&J deal would be the biggest biotech deal in over a year and will add treatments for disorders of the central nervous ...

Intra-Cellular Therapies ITCI signed a definitive agreement with pharma bigwig Johnson & Johnson JNJ. Per the terms, the pharma giant will acquire all outstanding shares of ITCI for $132 per share ...

Johnson & Johnson has struck a $14.6bn deal to buy neuroscience drugmaker Intra-Cellular Therapies, the US pharmaceutical company said, marking the biggest biotech buyout in more than a year.

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday ... and long-term growth catalyst for Johnson & Johnson and offers compelling value to patients, health systems and ...

Scientists are trialling an innovative new drug that could offer hope to patients with advanced ... pathway, which is a cellular defence mechanism exploited by cancer cells to support their ...

As cold temperatures arrive, UScellular offers the following tips to help protect your smartphone: • Keep your phone fully charged. Cold weather can cause your battery to drain more quickly ...